Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elizabeth A. Lutz"'
Publikováno v:
International Journal of Clinical Practice. 2022:1-7
Background. The SARS-CoV-2 (COVID-19) pandemic resulted in major shifts in service delivery for patient care not involving COVID-19 illness. The preexisting telehealth infrastructure in Mississippi allowed the state to rapidly expand the scope of tel
Publikováno v:
Veterinary Ophthalmology. 16:386-391
A 5-year-old spayed female diabetic mixed-breed dog underwent phacoemulsification and intraocular lens implantation to correct bilateral hypermature cataracts. Two months postsurgery, the patient presented with ulcerative keratitis and multifocal str
Autor:
Elizabeth A. Lutz, Harlan E. Shannon
Publikováno v:
Neuropharmacology. 42:253-261
The effects of the peripherally restricted opioid agonist loperamide were compared to those of morphine in the formalin test in rats. Both loperamide and morphine were efficacious in producing antihyperalgesia after both subcutaneous and intracistern
Publikováno v:
Veterinary ophthalmology. 18(3)
Background The aim of the study was to evaluate ex vivo the effects of using a custom tip to direct a pulsed stream of fluid to remove residual lens epithelial cells (LECs) and reduce posterior capsule opacification (PCO) formation following phacoemu
Autor:
Heather L. Chandler, David A. Wilkie, Anne J. Gemensky-Metzler, Elizabeth A. Lutz, David J. Haeussler
Publikováno v:
Investigative ophthalmologyvisual science. 53(4)
PURPOSE Because hyaluronic acid (HA) is found in many surgical viscoelastic agents, this study aimed to determine (1) if HA receptors are present in the canine lens, (2) if the rate of lens epithelial cell (LEC) migration is altered following treatme
Autor:
Harlan E. Shannon, Elizabeth A. Lutz
Publikováno v:
Pain. 85(1-2)
Moxonidine is a mixed I(1) imidazoline/alpha(2)moxonidine=morphine. The I(1) imidazoline preferring antagonist efaroxan produced a dose-dependent antagonism of both moxonidine (5.0 mg/kg) and clonidine (0.5 mg/kg). In addition, the alpha(2)-adrenergi